Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01177 SINO BIOPHARM
RT Nominal up8.170 +0.450 (+5.829%)
Latest  |  Final  |  Interim
Non-current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Investment Properties248,619-7.587%269,030289,342720,754705,626
Property, plant, equip. & others8,493,098-2.281%8,691,3828,080,9077,759,5927,154,298
Land & other Lease Assets1,560,717-2.258%1,596,7741,831,2541,491,5911,361,764
Intangible Assets3,119,4551.911%3,060,9662,908,9611,914,4501,711,946
Interests in Asso. & JCEs1,590,863-1.804%1,620,08512,243,67513,198,15714,266,396
Other Non-current Assets26,061,3362.263%25,484,50114,445,14913,044,83511,840,129

41,074,0880.863%40,722,73839,799,28838,129,37937,040,159
Current Assets
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Inventories2,103,865-11.347%2,373,1451,993,4722,328,8441,937,741
Trade Receivables8,154,08064.147%4,967,5604,510,1954,638,3964,220,667
Cash & Bank Balances11,104,40216.039%9,569,5849,451,87812,066,21710,568,812
Other Current Assets12,457,97160.230%7,775,0426,937,2806,901,4486,775,958
Assets Held for Sale0--0912,70600

33,820,31837.006%24,685,33123,805,53125,934,90523,503,178
Current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Trade Payables2,820,27788.337%1,497,4611,334,7031,637,3511,693,152
S-T Debt & Leases8,872,45116.278%7,630,40111,207,4289,723,8416,585,038
Other Current Liabilities13,157,88226.171%10,428,6289,825,7858,789,4857,066,829
Liab asso w/ Assets Held for Sale0--0238,85900

24,850,61027.071%19,556,49022,606,77520,150,67715,345,019
Net Current Assets8,969,70874.888%5,128,8411,198,7565,784,2288,158,159
Total Assets Less Current Liabilities50,043,7969.143%45,851,57940,998,04443,913,60745,198,318
Non-current Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
L-T Debt & Leases3,083,46048.233%2,080,1451,372,8164,258,1225,532,475
Other Non-current Liabilities1,182,62118.575%997,3641,455,2751,711,9371,936,820

4,266,08138.621%3,077,5092,828,0915,970,0597,469,295
Capital and Reserves
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
  Share Capital413,680-0.170%414,384414,615414,899415,440
  Reserves32,959,8944.481%31,546,40530,059,85429,332,13629,875,676
  Others0--0000
Shareholders' Funds33,373,5744.420%31,960,78930,474,46929,747,03530,291,116
Non-controlling Interests12,404,14114.712%10,813,2817,695,4848,196,5137,437,907
Others0--0000

45,777,7157.022%42,774,07038,169,95337,943,54837,729,023
Commitments and Contingent Liabilities
2025/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Commitments----1,517,577535,5461,811,239950,038
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 22/08/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 3,388,591
%Change12.311%
EPS / (LPS)RMB 0.188
NBV Per Share (¥)RMB 1.779
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.